Capsulomics: Stacey Gilbert, Lisa Kann
Capsulomics has appointed Stacey Gilbert as vice president of market access and reimbursement and Lisa Kann as vice president of product development and strategy.
Gilbert will lead efforts to optimize government and private companies' coverage, coding, and reimbursement for Capsulomics' testing portfolio. Before joining Capsulomics, she was the senior director of population health and director of market access strategy for Exact Sciences. She also has prior experience in sales and market access at Sankyo Pharma, CV Therapeutics, Gilead Sciences, Zoll LifeVest, SomnoMed, and Medac Pharma.
Kann was previously the director of lab planning and project management at Thrive Earlier Detection, which was acquired by Exact Sciences in 2021. She also was head of laboratory operations at Papgene, VP of laboratory operations at Personal Genome Diagnostics, scientist and manager at Genzyme Genetics, and principal scientist at Exact Sciences.